Gaurav D. Shah
2019
In 2019, Gaurav D. Shah earned a total compensation of $3.9M as President and Chief Executive Officer at Inotek Pharmaceuticals, a 39% decrease compared to previous year.
Compensation breakdown
| Bonus | $349,140 |
|---|---|
| Option Awards | $3,043,306 |
| Salary | $480,000 |
| Other | $11,200 |
| Total | $3,883,646 |
Shah received $3M in option awards, accounting for 78% of the total pay in 2019.
Shah also received $349.1K in bonus, $480K in salary and $11.2K in other compensation.
Rankings
In 2019, Gaurav D. Shah's compensation ranked 3,085th out of 13,971 executives tracked by ExecPay. In other words, Shah earned more than 77.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,085 out of 13,971 | 78th |
Division Manufacturing | 1,115 out of 5,695 | 80th |
Major group Chemicals And Allied Products | 378 out of 2,194 | 83rd |
Industry group Drugs | 311 out of 1,880 | 84th |
Industry Pharmaceutical Preparations | 229 out of 1,392 | 84th |
Source: SEC filing on April 24, 2020.
Shah's colleagues
We found two more compensation records of executives who worked with Gaurav D. Shah at Inotek Pharmaceuticals in 2019.